An assessment of urethral radiation exposure in the treatment of endometrial and rectal cancers
- 1 October 2022
- journal article
- research article
- Published by Springer Nature in International Urogynecology Journal
- Vol. 34 (4) , 929-935
Abstract
Introduction and hypothesis Female survivors of endometrial and rectal cancers have increased risk of urinary incontinence. Survivors with prior radiation therapy are counseled against mesh incontinence surgery. We hypothesize that urethral radiation dose varies based on modality which may influence surgical risks. We aimed to demonstrate urethral radiation dose differences between vaginal brachytherapy (VBT) and external beam radiation therapy (EBRT). Methods This is a retrospective cohort study of women exposed to VBT for endometrial cancer and EBRT for rectal cancer. The urethra was contoured on CT imaging to calculate radiation doses in centigray (cGy). The primary outcome was the percent of treatment radiation dose estimated to be received by the urethra based on the volume dose to 0.2 cc of urethra. Secondary outcomes were point doses to the bladder neck, mid-urethra, and total mean urethral dose. Descriptive statistics described demographic characteristics. Bivariate analyses compared urethral radiation dose based on radiation modality. Results Between 2014–2017, 32 women treated were included: 18 with VBT and 14 with EBRT. Mean ± SD urethral volume doses were lower in VBT (1266 cGy ± 533, 42.2% of prescribed treatment dose) compared to EBRT (5051 cGy ± 192, 100.2% of prescribed treatment dose), p < 0.0001. VBT also had significantly lower mean total urethral dose and point doses to bladder neck and mid- urethra compared to EBRT (p < 0.0001). Conclusions The female urethra is exposed to significantly less radiation in VBT compared to EBRT. These data highlight that modality of pelvic radiation should be considered in treatment counseling on urinary incontinence in women.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1TR001420)
This publication has 17 references indexed in Scilit:
- Basic Principles in Gynecologic Radiotherapy2018
- Computed tomography–planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicityBrachytherapy, 2016
- Computed tomography planned interstitial brachytherapy for recurrent gynecologic cancerBrachytherapy, 2015
- Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population‐based cross‐sectional studyColorectal Disease, 2014
- Fractionation in normal tissues: the (α/β)effconcept can account for dose heterogeneity and volume effectsPhysics in Medicine & Biology, 2013
- Urethral dosimetry and toxicity with high-dose-rate interstitial brachytherapy for vaginal cancerBrachytherapy, 2013
- Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: Clinical outcomes and dose–volume histogram analysisBrachytherapy, 2012
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialThe Lancet, 2010
- Urinary symptoms and impact on quality of life in women after treatment for endometrial cancerInternational Urogynecology Journal, 2008
- A new isoeffect curve for change in dose per fractionRadiotherapy and Oncology, 1983